Eric Stonestreet tells Business Insider how he's adapted to life's twists and turns, from being cast in one of the biggest ...

Andy Richter said he looked into taking weight-loss drugs despite not having type 2 diabetes. However, his insurance company ...

Lilly, meanwhile, has just raised the stakes in the category with its first-in-class combined GLP-1/GIP agonist Mounjaro (tirzepatide), recently approved for diabetes and in late-stage testing in ...